CONTEXT: Increased hepatic de novo lipogenesis (DNL) in response to dietary sugar is implicated in dyslipidemia, fatty liver, and insulin resistance. OBJECTIVE: The aim of the study was to develop a simple outpatient tolerance test for lipogenic sensitivity to dietary sugar. DESIGN AND SETTING: In inpatients given repeated doses of fructose, protocol 1 compared the acute increase in DNL determined from the percentage of palmitate ("new palmitate") and the percentage of isotopically labeled palmitate ("%DNL") in very low-density lipoprotein triglyceride (TG). Protocol 2 compared the increase in new palmitate in outpatients given three different sugar beverages in a randomized crossover design. PARTICIPANTS: There were 15 lean and overweight volunteers in protocol 1 and 15 overweight volunteers in protocol 2. INTERVENTIONS: In protocol 1, subjects received 1.4 g/kg fructose in divided oral doses over 6 h; in protocol 2, subjects received 0.5 g/kg fructose, 0.5 g/kg fructose plus 0.5 g/kg glucose, or 1 g/kg fructose plus 1 g/kg glucose each as a single oral bolus. MAIN OUTCOME MEASURES: We measured the increase in DNL by two methods. RESULTS: After repeated doses of fructose, new palmitate was significantly correlated with the increase in %DNL (Δ, r = 0.814; P < 0.001) and with fasting insulin levels (area under the curve, r = 0.754; P = 0.001). After a single sugar dose, new palmitate showed a dose effect and was greater after fructose plus glucose. Very low-density lipoprotein TG and total TG significantly increased in both protocols. CONCLUSIONS: A single oral bolus of fructose and glucose rapidly increases serum TG and TG palmitate in overweight subjects. A dual sugar challenge test could prove useful to identify individuals at risk for carbohydrate-induced dyslipidemia and other adverse effects of increased DNL.
RCT Entities:
CONTEXT: Increased hepatic de novo lipogenesis (DNL) in response to dietary sugar is implicated in dyslipidemia, fatty liver, and insulin resistance. OBJECTIVE: The aim of the study was to develop a simple outpatient tolerance test for lipogenic sensitivity to dietary sugar. DESIGN AND SETTING: In inpatients given repeated doses of fructose, protocol 1 compared the acute increase in DNL determined from the percentage of palmitate ("new palmitate") and the percentage of isotopically labeled palmitate ("%DNL") in very low-density lipoprotein triglyceride (TG). Protocol 2 compared the increase in new palmitate in outpatients given three different sugar beverages in a randomized crossover design. PARTICIPANTS: There were 15 lean and overweight volunteers in protocol 1 and 15 overweight volunteers in protocol 2. INTERVENTIONS: In protocol 1, subjects received 1.4 g/kg fructose in divided oral doses over 6 h; in protocol 2, subjects received 0.5 g/kg fructose, 0.5 g/kg fructose plus 0.5 g/kg glucose, or 1 g/kg fructose plus 1 g/kg glucose each as a single oral bolus. MAIN OUTCOME MEASURES: We measured the increase in DNL by two methods. RESULTS: After repeated doses of fructose, new palmitate was significantly correlated with the increase in %DNL (Δ, r = 0.814; P < 0.001) and with fasting insulin levels (area under the curve, r = 0.754; P = 0.001). After a single sugar dose, new palmitate showed a dose effect and was greater after fructose plus glucose. Very low-density lipoprotein TG and total TG significantly increased in both protocols. CONCLUSIONS: A single oral bolus of fructose and glucose rapidly increases serum TG and TGpalmitate in overweight subjects. A dual sugar challenge test could prove useful to identify individuals at risk for carbohydrate-induced dyslipidemia and other adverse effects of increased DNL.
Authors: Kitt Falk Petersen; Sylvie Dufour; David B Savage; Stefan Bilz; Gina Solomon; Shin Yonemitsu; Gary W Cline; Douglas Befroy; Laura Zemany; Barbara B Kahn; Xenophon Papademetris; Douglas L Rothman; Gerald I Shulman Journal: Proc Natl Acad Sci U S A Date: 2007-07-18 Impact factor: 11.205
Authors: Rachel K Johnson; Lawrence J Appel; Michael Brands; Barbara V Howard; Michael Lefevre; Robert H Lustig; Frank Sacks; Lyn M Steffen; Judith Wylie-Rosett Journal: Circulation Date: 2009-08-24 Impact factor: 29.690
Authors: Richard J Johnson; Mark S Segal; Yuri Sautin; Takahiko Nakagawa; Daniel I Feig; Duk-Hee Kang; Michael S Gersch; Steven Benner; Laura G Sánchez-Lozada Journal: Am J Clin Nutr Date: 2007-10 Impact factor: 7.045
Authors: Kimber L Stanhope; Steven C Griffen; Brandi R Bair; Michael M Swarbrick; Nancy L Keim; Peter J Havel Journal: Am J Clin Nutr Date: 2008-05 Impact factor: 7.045
Authors: Kimber L Stanhope; Valentina Medici; Andrew A Bremer; Vivien Lee; Hazel D Lam; Marinelle V Nunez; Guoxia X Chen; Nancy L Keim; Peter J Havel Journal: Am J Clin Nutr Date: 2015-04-22 Impact factor: 7.045
Authors: Jennifer C Rood; Jean-Marc Schwarz; Thomas Gettys; Randall Ll Mynatt; Tamara Mendoza; William D Johnson; William T Cefalu Journal: Nutrition Date: 2014-04-18 Impact factor: 4.008
Authors: Jean-Marc Schwarz; Susan M Noworolski; Michael J Wen; Artem Dyachenko; Jessica L Prior; Melissa E Weinberg; Laurie A Herraiz; Viva W Tai; Nathalie Bergeron; Thomas P Bersot; Madhu N Rao; Morris Schambelan; Kathleen Mulligan Journal: J Clin Endocrinol Metab Date: 2015-03-31 Impact factor: 5.958
Authors: Jibran A Wali; Annabelle J Milner; Alison W S Luk; Tamara J Pulpitel; Tim Dodgson; Harrison J W Facey; Devin Wahl; Melkam A Kebede; Alistair M Senior; Mitchell A Sullivan; Amanda E Brandon; Belinda Yau; Glen P Lockwood; Yen Chin Koay; Rosilene Ribeiro; Samantha M Solon-Biet; Kim S Bell-Anderson; John F O'Sullivan; Laurence Macia; Josephine M Forbes; Gregory J Cooney; Victoria C Cogger; Andrew Holmes; David Raubenheimer; David G Le Couteur; Stephen J Simpson Journal: Nat Metab Date: 2021-06-08
Authors: Derek M Erion; Violetta Popov; Jennifer J Hsiao; Daniel Vatner; Kisha Mitchell; Shin Yonemitsu; Yoshio Nagai; Mario Kahn; Matthew P Gillum; Jianying Dong; Susan F Murray; Vara Prasad Manchem; Sanjay Bhanot; Gary W Cline; Gerald I Shulman; Varman T Samuel Journal: Endocrinology Date: 2012-11-16 Impact factor: 4.736
Authors: Mary Courtney Moore; Marta S Smith; Larry L Swift; Anthony H Cincotta; Michael Ezrokhi; Nicholas Cominos; Yahong Zhang; Ben Farmer; Alan D Cherrington Journal: Am J Physiol Endocrinol Metab Date: 2020-05-27 Impact factor: 4.310